Overview
L‑citrulline is a non‑essential amino acid that converts to L‑arginine, thereby increasing nitric‑oxide (NO) bioavailability. In cardiovascular health, NO promotes vasodilation, improves endothelial function and may reduce vascular stiffness—mechanisms indirectly relevant to atrial fibrillation (AFib). Although direct randomized AF outcome trials for citrulline are limited, supporting evidence from vascular and perioperative literature plus human metabolomics suggests a plausible role as part of a comprehensive strategy alongside lifestyle and medical care.
How Citrulline Might Help in AFib
1) Increasing NO bioavailability
Citrulline efficiently raises plasma arginine more consistently than oral arginine due to first‑pass metabolism differences. Greater NO availability can enhance endothelial function and microvascular flow. Better vascular health may lower triggers such as blood‑pressure spikes and improve overall cardiac workload.
2) Endothelial function and stiffness
Human supplementation studies outside AF consistently show improvements in flow‑mediated dilation and surrogate markers of arterial stiffness after citrulline. While not AF‑specific, these endpoints relate to cardiovascular risk and may influence the substrate in which AF arises or persists.
3) Perioperative/NO donor context
Randomized trials with NO donors (e.g., sodium nitroprusside) reduced post‑operative AF after CABG. Citrulline is not a NO donor, but by enhancing NO pathways, it supports a mechanistic line consistent with these outcomes. This should be viewed as indirect evidence.
Evidence Summary
- NO donors and post‑op AF: In CABG trials, AF incidence and duration were reduced under NO donor therapy (see Research).
- Human metabolomics: Plasma citrulline increased after successful catheter ablation, correlating with restored sinus rhythm (association, not causation).
- Systematic reviews: Oral citrulline increases arginine and NO bioavailability and improves vascular function, though AF‑specific outcome trials are scarce.
For full citations and notes, visit the site’s Research section.
Suggested Dosage (Informational)
Common supplemental ranges are 3–6 g/day, often split into 2–3 doses to improve tolerance. Individuals may start lower and titrate. Those on antihypertensives or PDE‑5 inhibitors should consult their clinician due to potential additive vasodilation.
- Form: L‑citrulline powder or tablets; citrulline malate is also common in sports nutrition (note the malate component).
- Timing: Split across the day; for exercise, a pre‑activity dose is sometimes used in performance literature.
- Stacking: Can be combined with lifestyle measures targeting blood pressure, sleep and stress (see Triggers).
Safety and Interactions
Citrulline is generally well tolerated. Potential issues include GI discomfort at higher doses and additive effects with blood‑pressure lowering agents or PDE‑5 inhibitors. Patients with complex medical histories, kidney disease or pregnancy should seek personalized medical advice.
Practical Tips
- Use citrulline as part of a broader AFib plan: address triggers, optimize sleep, moderate alcohol and maintain hydration.
- Monitor blood pressure and symptoms; discuss trends with your clinician.
- Reassess need and dose after rhythm procedures (e.g., ablation) or medication changes.
Medical disclaimer: This page is informational and not medical advice. AF‑specific outcome evidence for citrulline remains limited; always consult your physician.